Isomorphic Labs is the secretive AI life science startup spun out of Google DeepMind with the goal of solving all disease ...

The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...

Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...

The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...

AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...

Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...

The funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.

Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and ...

On a rare sunny day in London at the Google DeepMind office, Colin Murdoch saw the bank deposit from his employer come through. It wasn't his paycheck. Google was investing in his startup.

It wasn't his paycheck. Google was investing in his startup. The fledgling company was Isomorphic Labs, the secretive artificial intelligence life sciences startup spun out of Google DeepMind ...